Various systemic therapies for psoriasis either reduced, slightly increased or had no effect on risk for major adverse ...

Ultrasound-detected bursitis and higher baseline BMI are associated with the development of musculoskeletal symptoms in ...

A new study published in the journal of Photodermatology, Photoimmunology and Photomedicine showed that people with psoriasis ...

This excerpt from ‘Glowing Skin and Gorgeous Hair’ explains how our skin is a window into our emotional and mental health ...

Researchers have identified in a new study that increased serum 25-hydroxyvitamin D (25(OH)D) is linked with lower risks of ...

Arcutis Biotherapeutics has enrolled the first child in an open-label Phase II trial of Zoryve (roflumilast) for atopic ...

Discover why nails separate from the nail bed, what causes onycholysis, and how to treat this common but concerning nail ...

ZORYVE cream, 0.3%, is indicated for topical treatment of plaque psoriasis, including intertriginous areas, in adult and pediatric patients 6 years of age and older. ZORYVE cream, 0.15%, is indicated ...

Two recent studies suggest there is no significant benefit of early biologics over standard step-up care with methotrexate2,3, but these did not ...

pointing out that psoriasis affects over a million people across the UK “and, for some, it can have a significant life impact.” “It is therefore hugely important for the community to have ...